FOXP3 and cancer: Our finding that miR-155 participates in the control of ZEB2, a key component of the regulatory circuit governing EMT, supports a complex role for miR-155 in cancer, consistent with the notion that cancer progression may be dependent on the interaction of a number of different factors, including the presence of other mutations in the cell, and the loss of master regulators such as FOXP3.